EMA Seeks to Revise Guidance on First-In-Human Trials

Article

Pharmaceutical Executive

July 22, 2016

The European Medicines Agency (EMA) is proposing changes to the current guidelines on first-in-human clinical trials to improve risk-based strategies. This proposal was made with cooperation from the European Commission and the Member States of the European Union (EU).

Read the full release here

Recent Videos
Ted Sweetser
Ted Sweetser
Ted Sweetser
Matthew Yelovich, Cleary Gottlieb, Theranos Case
Jennifer Kyle, Condor
Related Content
Faruk Capan

EVERSANA Launches ORCHESTRATE MLR Platform: Q&A with Faruk Capan

Mike Hollan
May 1st 2025
Article

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Pete Foley

$25B Potential in Accelerating AI’s Impact and Value in Pharma

Pete Foley
April 29th 2025
Article

Pooja Lal

Effectiveness Not Volume: Q&A with Pooja Lal

Pharmaceutical Executive
April 24th 2025
Article

AI is transforming content reviews to focus on relevant use, not just generation.

Using AI to Predict Launch Success

Using AI to Predict Launch Success

Anirudh Singh Rathore;Rahul Mathur
April 17th 2025
Article

How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.

Translating ‘Digital-First’ to Commercial Success

Translating ‘Digital-First’ to Commercial Success

Shetal Vyas
April 15th 2025
Article

Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.